Monopar Therapeutics (MNPR) Shares Issued (2017 - 2025)

Monopar Therapeutics has disclosed Shares Issued across 7 years of filings, most recently posting $544800.0 for Q4 2025.

• Shares Issued for Q4 2025 came in at $544800.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $565171.0 (up 672722.62% YoY), and the FY2025 annual result was $565171.0, up 672722.62% from the prior year.
• Shares Issued came in at $544800.0 for Q4 2025 at Monopar Therapeutics, up from $20371.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $821625.0 in Q1 2023 to a low of -$1.5 million in Q3 2023.
• The 5-year median for Shares Issued is $16462.5 (2021), against an average of $58290.2.
• Across the five-year window, Shares Issued plunged 99.99% in 2024 and sank 18489.29% in 2025, its largest moves.
• Monopar Therapeutics' Shares Issued stood at $17478.0 in 2021, then slumped by 99.03% to $169.0 in 2022, then tumbled by 875494.08% to -$1.5 million in 2023, then surged by 100.01% to $84.0 in 2024, then surged by 648471.43% to $544800.0 in 2025.
• The last three Shares Issued figures came in at $544800.0 (Q4 2025), $20371.0 (Q3 2025), and -$15447.0 (Q2 2025), per Business Quant data.